EDGAR Filing Documents for 0001144204-16-128086

Form 8-K - Current report:

SEC Accession No. 0001144204-16-128086

Filing Date

2016-10-14

Accepted

2016-10-14 09:30:24

Documents

Period of Report

2016-10-12

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v450529_8k.htm	8-K	31102
2	EXHIBIT 99.01	v450529_ex99-01.htm	EX-99.01	8068
3	EXHIBIT 99.02	v450529_ex99-02.htm	EX-99.02	7925
4	GRAPHIC	image_001.jpg	GRAPHIC	73922
	Complete submission text file	0001144204-16-128086.txt		150390

Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258

Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112

Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)